PDCD1 and Alzheimer disease: In fact, it is important to note that several PD-1 antibody inhibitors developed for other indications activate the peripheral immune system, but fail to modulate monocyte-derived macrophage infiltration and progression of brain Aβ pathology in three different models of AD [399,400].